Rise in oral cancers among young nonsmokers points to immunodeficiencyMarch 24, 2022Head & Neck/Thyroid Cancers
Few new cancer drugs replace current standards of careMarch 24, 2022Mixed TopicsGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
Ways to lessen toxic effects of chemo in older adultsMarch 17, 2022Patient & Survivor CareCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Radioactive iodine shows no benefit in low-risk thyroid cancerMarch 10, 2022Head & Neck/Thyroid Cancers
Filling opioid prescriptions akin to a Sisyphean taskMarch 8, 2022Opioid Resource CenterGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung CancerMetastatic Breast Cancer
Can liquid biopsy predict oropharyngeal cancer recurrence?March 3, 2022Head & Neck/Thyroid CancersMixed Topics
Radiofrequency ablation an option for thyroid microcarcinomaFebruary 24, 2022Head & Neck/Thyroid Cancers
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinomaFebruary 17, 2022Head & Neck/Thyroid Cancers
“I didn’t want to meet you.” Dispelling myths about palliative careFebruary 2, 2022Patient & Survivor CarePreventive CareMixed TopicsGastrointestinal CancerHead & Neck/Thyroid CancersGynecologic CancerGenitourinary Cancer
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancerFebruary 1, 2022Gastrointestinal CancerHead & Neck/Thyroid Cancers
No link between mother’s pill use and CNS tumors in offspringJanuary 5, 2022CNS/Brain CancerNeuro-oncologyHead & Neck/Thyroid Cancers
‘Outstanding’ outcomes: Reduced postop radiation in HPV, oropharynx cancerJanuary 5, 2022Head & Neck/Thyroid Cancers
